ALVEOLIX AG
AlveoliX provides in-vitro solutions based on proprietary and unique organ-on-chip technologies aimed at improving preclinical decision-making and thus reducing drug development costs. AlveoliX aims at changing the way drug development research is done today by providing in-vitro models that reproduce the in-vivo environment in an unprecedented way. These in-vitro models, called organ-on-chips, will make it possible to better predict drugs’ responses in humans than standard in-vitro and in-vivo models and as a consequence to importantly reduce animal testing.
ALVEOLIX AG
Social Links:
Industry:
Biotechnology Life Science
Founded:
2019-01-01
Address:
Berne, Bern, Switzerland
Country:
Switzerland
Website Url:
http://www.alveolix.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
33.46 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics Wordpress Plugins
Current Employees Featured
Founder
Investors List
Eurostars
Eurostars investment in Grant - AlveoliX AG
Official Site Inspections
http://www.alveolix.com
- Host name: s033.cyon.net
- IP address: 149.126.4.42
- Location: Switzerland
- Latitude: 47.1449
- Longitude: 8.1551
- Timezone: Europe/Zurich
